CLOs on the Move

Embecta

www.embecta.com

 
Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.embecta.com
  • 1 Becton Drive
    Franklin Lakes, NJ USA 07417
  • Phone: 201.847.6800

Executives

Name Title Contact Details
Jeff Mann
Senior Vice President, General Counsel and Head of Corporate Development Profile

Similar Companies

Clearside Biomedical

Clearside Biomedical, Inc. is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding diseases of the eye.

Cylene Pharmaceuticals

Cylene Pharmaceuticals Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Intercept Pharmaceuticals

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients` lives and addressing the liver community`s most pressing needs. Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia.

Cobalt Pharmaceuticals

Cobalt Pharmaceuticals Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.